Leadership Message

We are pleased to present the 2019 Annual Report for the Princess Margaret Cancer Centre at University Health Network (UHN). This report profiles our progress and activities in clinical care, research and education in the past year.

For the Princess Margaret, 2019 was a year of growth and reflection. We launched our new strategic plan, Future Care Now: Create Cancer Care for 2030, which outlines the foundational essentials and new strategic priorities that will guide our efforts to achieve impact as one of the top comprehensive cancer centres in the world. In alignment with our new strategy, we made progress in advancing data science, expanded our global partnerships, implemented new advances in care, and furthered our understanding of cancer through clinical, translational and basic research. The Princess Margaret clinical trials program continues to grow in volume and breadth with 2,765 patients enrolled in clinical trials in 2019.

With impending transitions in the Centre’s leadership in 2020, an external review was commissioned by Dr. Kevin Smith, UHN CEO, and Dr. Brian Hodges, UHN Chief Medical Officer, to critically assess the Centre’s progress, current state, future plans and ambitions. The reviewers endorsed the Centre’s aspiration to be a top 5 Cancer Centre in the world and provided a unique perspective on our plans to continue to impact cancer care at a global scale.

Read More

We also experienced a significant shift in the governance of cancer care across the province. One central agency, Ontario Health, now oversees all cancer care delivery and clinical guidance to ensure the best quality care for patients. The Princess Margaret will continue to work closely with Ontario Health-Cancer Care Ontario, to facilitate system-wide collaboration and improvement.

We acknowledge the crucial role of the Princess Margaret Cancer Foundation in its tremendous support and philanthropic efforts that help make our programs and innovation agenda possible. We thank our donors, granting agencies, sponsors, and supporters for their continued patronage.

Finally, we extend our gratitude to our staff and volunteers for their relentless dedication and determination in providing the very highest standard of care and support for our patients, and for continually pushing the boundaries of innovation and collaboration.

Read Less
Headshot of Marnie Escaf

Marnie Escaf
MHA, HBBA

Senior Vice President, Executive Lead Princess Margaret Cancer Centre

Headshot of Mary Gospodarowicz

Mary Gospodarowicz
MD, FRCPC, FRCR (Hon)

Medical Director, Princess Margaret Cancer Centre

Headshot of Aaron D Schimmer

Aaron D Schimmer
MD, PhD, FRCPC

Research Director, Princess Margaret Cancer Centre

 

Quick Facts

Use the buttons below to navigate through the quick facts.

Patients
82,571 Total Unique Patients Seen
17,433
New Patients
12,545
Malignant
3,444
Non-Neoplastic
1,444
Benign
New Malignant Diagnosis by Disease Group
  1903 Genitourinary
  1813 Gastrointestinal
  1694 Breast
  1225 Thoracic
  1012 Gynecology
  801 Leukemia & Other Hematology
  786 Head & Neck
  624 Thyroid/endocrine
  621 Lymphoma
  457 Bone & Sarcoma
  356 Skin (Not Melanoma)
  350 Central Nervous System
  296 Melanoma
  207 Myeloma
  205 Eye
  195 Other
Size
850,000 sqft
Clinical Space
329,400 sqft
Research Space
264
Beds Across UHN
People
3,420 Total
187
Oncologists
570
Nurses
562
Health Professions Staff
1,304
Researchers / Research Staff
Clinical Care
6,387
Surgical Procedures
88,555
Radiation Therapy Visits
52,949
Systemic Therapy & Transfusion Visits
485
Stem Cell Transplants
254,013 Clinic Visits
Research
$146.7M
Research Funding
1,062
Peer-Reviewed Publications
193
New Clinical Research Studies Opened
7,879
Patients in Clinical Research Studies
2,765
Patients Entered in Clinical Trials
22%
of Patients in Clinical Trials
Education
119
Nursing Students
146
Residents
186
Health Professions Students
176
Fellows
270
Research Trainees
2,298
Participants in Enrichment Programs
 

Past Reports

Princess Margaret Cancer Centre Annual Reports

Strategies & Plans

Back to top
Last reviewed:
Last modified: 9/24/2020 6:07 AM